PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 7682136

Mechanism of staurosporine-induced decrease in acetylcholine receptor recovery from desensitization.

J C Hardwick·R L Parsons
View original source ↗Export metadata ↓

Abstract

1. Previously, we showed in voltage-clamped snake twitch muscle fibres that the extent of recovery of the nicotinic acetylcholine (ACh) receptor from carbachol-induced desensitization is reduced by pretreatment with the protein kinase inhibitor staurosporine. The present studies were undertaken to determine the mechanism underlying the staurosporine-induced inhibition of recovery. 2. Pretreatment with 0.5 microM staurosporine significantly decreased the extent of recovery of spontaneous miniature endplate current (m.e.p.c.) amplitudes in preparations exposed to 540 microM carbachol. The decrease in recovery of m.e.p.c. amplitude by staurosporine was dependent on the duration of carbachol exposure. No significant decrease in m.e.p.c. amplitude was observed with a 1 min exposure to agonist, whereas a significant decrease in recovery was seen with agonist exposures between 5-10 min. Further, the effect of staurosporine pretreatment on ACh receptor recovery was long-lasting such that m.e.p.c. amplitude remained decreased for at least 60 min. 3. Estimation of mean channel conductance by noise analysis during local perfusion of 20 microM carbachol demonstrated a decrease in conductance from 52 pS to 23 pS in staurosporine-treated preparations following recovery from desensitization. Staurosporine treatment in the absence of desensitization did not alter the mean channel conductance. 4. A single population of ACh-activated single channel currents with a conductance of 45-49 pS was recorded in cell-attached patches from enzymatically cleaned endplates in control and staurosporine-treated preparations not exposed to carbachol. 5. At staurosporine-treated endplates exposed to carbachol and then allowed to recover, a population of small conductance (23 pS) channels was observed. These channels were not normally seen in control preparations which had undergone carbachol-induced desensitization and recovery.6. We suggest that the decrease in m.e.p.c. amplitude observed following recovery from desensitization in staurosporine-treated endplates results from the activation of a mixture of small and large conductance ACh receptor channels.

Explore related subjects

AlkaloidsAnimalsCarbacholDepression, ChemicalElectrophysiologyIn Vitro TechniquesIon ChannelsMotor EndplateMusclesProtein Kinase CReceptors, CholinergicSnakesStaurosporineJournal ArticleResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J C Hardwick, R L Parsons. 1993. Mechanism of staurosporine-induced decrease in acetylcholine receptor recovery from desensitization.. https://doi.org/10.1111/j.1476-5381.1993.tb12871.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1996

Evaluation of micellar electrokinetic capillary chromatography for the analysis of selected tobacco alkaloids.

Micellar electrokinetic capillary chromatography was evaluated for simultaneous determination of several tobacco alkaloids with similar molecular structure. Satisfactory separation of nicotine, nornicotine, myosmine, anatabine and anabasine extracted from tobacco was achieved by introducing an ionic surfactant, sodium dodecyl sulfate, into the buffer system at a concentration of 100 mM. Sample preparation involved a single extraction with water containing 1% triethanolamine. Separation was performed on a 72 cm long, uncoated fused-silica capillary. Experimental parameters such as applied voltage, pH value, buffer composition and surfactant concentration were optimized. Enhancement of UV absorption of alkaloids in the presence of micelles was also studied.

Alkaloids↗
PubMed1996

Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53.

Brefeldin A (BFA) is a natural product that affects the structure and function of the Golgi apparatus and is in development for cancer chemotherapy. We observed that a wide range of cancer cells could undergo DNA fragmentation associated with apoptosis after BFA treatment. This DNA fragmentation was induced within 15 h in HL60 leukemia cells and after 48 h in K562 leukemia and HT-29 colon carcinoma cells with BFA concentrations as low as 0.1 microM. The DNA fragmentation had the typical internucleosomal pattern in HL60 and HT-29 cells. Apoptotic cells were also detected by microscopy. BFA-induced apoptosis is p53-independent as HL60 and K562 cells are p53 null and HT-29 are p53 mutant cells. BFA could potentiate UCN-01 and staurosporine-induced DNA fragmentation in HL60 cells. Cyclin B1/Cdc2 kinase activity decreased after BFA treatment in HL60 cells, indicating that BFA-induced DNA fragmentation was independent of a cyclin B1/Cdc2 kinase upregulation pathway. Cycloheximide could not prevent BFA-induced DNA fragmentation in HL60 cells, suggesting that protein synthesis is not needed for HL60 cells to undergo apoptosis. On the contrary, cycloheximide blocked BFA-induced DNA fragmentation in HT-29 cells, indicating that apoptosis in HT-29 cells requires macromolecular synthesis. Cell-free system experiments suggested that cytosolic proteins play an important role in triggering DNA fragmentation during apoptosis induced by BFA. Our results show that transduction signaling pathways play central roles in apoptotic regulation.

Alkaloids↗
PubMed1996

Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha.

The transcription factor NF-kappa B regulates genes participating in immune and inflammatory responses. In T lymphocytes, NF-kappa B is sequestered in the cytosol by the inhibitor I kappa B-alpha and released after serine phosphorylation of I kappa B-alpha that regulates its ubiquitin-dependent degradation. We report an alternative mechanism of NF-kappa B activation. Stimulation of Jurkat T cells with the protein tyrosine phosphatase inhibitor and T cell activator pervanadate led to NF-kappa B activation through tyrosine phosphorylation but not degradation of I kappa B-alpha. Pervanadate-induced I kappa B-alpha phosphorylation and NF-kappa B activation required expression of the T cell tyrosine kinase p56ick. Reoxygenation of hypoxic cells appeared as a physiological effector of I kappa B-alpha tyrosine phosphorylation. Tyrosine phosphorylation of I kappa B-alpha represents a proteolysis-independent mechanism of NF-kappa B activation that directly couples NF-kappa B to cellular tyrosine kinase.

Alkaloids↗